Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,884
datasets available to search
ShareScore release 0.9.0
Dataset results
2,884 results for “cancer resistance”
Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT00038428. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Determine the Feasibility, Evaluability and Variability in Markers of Drug Action in Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT02424448. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ipilimumab With Nivolumab for Molecular-selected Patients With Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT04717154. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT06067841. IPD Sharing: YES. Countries: 1. Publications: 0.
A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients
ClinicalTrials.gov study NCT05479045. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Identify Mechanisms of Resistance to Standard Therapy in Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT00984048. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT01639885. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients
ClinicalTrials.gov study NCT00044525. IPD Sharing: Not stated. Countries: 7. Publications: 0.
A Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of [225Ac]Ac-PSMA-XT Injection in Patients With Metastatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT07135102. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant, Advanced/Relapsed Ovarian Cancer Subjects Previously Treated With a PARP Inhibitor
ClinicalTrials.gov study NCT05475184. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT00084448. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer
ClinicalTrials.gov study NCT02935205. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer
ClinicalTrials.gov study NCT00077363. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer.
ClinicalTrials.gov study NCT06500247. IPD Sharing: NO. Countries: 1. Publications: 0.
Exercise Intervention for Pts With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide
ClinicalTrials.gov study NCT02130947. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer
ClinicalTrials.gov study NCT06315491. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Panitumumab and Pegylated Liposomal Doxorubicin for Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-type
ClinicalTrials.gov study NCT00861120. IPD Sharing: Not stated. Countries: 4. Publications: 0.
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT04986423. IPD Sharing: NO. Countries: 2. Publications: 0.
Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer
ClinicalTrials.gov study NCT06858449. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Unraveling KAdcyla Resistance In Human Epidermal Growth Factor Receptor 2(HER2) Positive Advanced Breast Cancer (KATIA)
ClinicalTrials.gov study NCT03829306. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.